Literature DB >> 31539774

PARP-1 mediated cell death is directly activated by ZIKV infection.

Gang Xu1, Shihua Li2, Xinyuan Liu3, Ping Gao2, Xiaotong Chen2, Haiyan Wang4, Mingxia Zhang4, Yang Yang4, George Fu Gao5, Fuping Zhang6.   

Abstract

Zika virus (ZIKV) has emerged as a severe health threat due to its association with microcephaly. It has been reported that the strong cytopathic effects, including cell-cycle arrest and cell death are responsible for the nervous system disease. However, the mechanisms by which ZIKV infection induced cell death were largely unknown. Here, we reported that cell death is readily detected after ZIKV infection as indicated by PI staining and the reduction of cell viability. Importantly, cell death can be induced by overexpression of ZIKV NS3 protein alone but not the other non-structure proteins. Mass spectrometry analysis revealed that NS3 bond to and activated PARP-1. In agreement with these observations, we found that PARP-1 was massively activated during ZIKV infection and the intracellular ATP and NAD+ concentrations rapidly declined. Finally, PARP-1 knockdown simultaneously restrained ZIKV infection-induced cell death and ablated host restriction of virus infection. Our finding indicates that PARP-1 activation is an important cellular event during ZIKV infection, which contributes to the cell death.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NAD(+); NS3; PARP-1; Programmed cell death; Zika virus

Mesh:

Substances:

Year:  2019        PMID: 31539774     DOI: 10.1016/j.virol.2019.08.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

Review 1.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 2.  ADP-ribosylation in evasion, promotion and exacerbation of immune responses.

Authors:  Maria Manuela Rosado; Claudio Pioli
Journal:  Immunology       Date:  2021-04-12       Impact factor: 7.215

Review 3.  Repositioning PARP inhibitors for SARS-CoV-2 infection(COVID-19); a new multi-pronged therapy for acute respiratory distress syndrome?

Authors:  Nicola Curtin; Krisztián Bányai; James Thaventhiran; John Le Quesne; Zsuzsanna Helyes; Péter Bai
Journal:  Br J Pharmacol       Date:  2020-07-05       Impact factor: 8.739

Review 4.  Flaviviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.

Authors:  Yuhong Pan; Wenjun Cai; Anchun Cheng; Mingshu Wang; Zhongqiong Yin; Renyong Jia
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

5.  SARM1 Depletion Slows Axon Degeneration in a CNS Model of Neurotropic Viral Infection.

Authors:  Colin L Crawford; Christina Antoniou; Lina Komarek; Verena Schultz; Claire L Donald; Paul Montague; Susan C Barnett; Christopher Linington; Hugh J Willison; Alain Kohl; Michael P Coleman; Julia M Edgar
Journal:  Front Mol Neurosci       Date:  2022-04-13       Impact factor: 6.261

6.  Shen Shuai II Recipe Attenuates Apoptosis in 5/6 Renal Ablation/Infarction Rats by Inhibiting p53 and the Mitochondrial Pathway of Apoptosis.

Authors:  Meng Wang; Jing Yang; Chen Wang
Journal:  Oxid Med Cell Longev       Date:  2020-02-07       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.